hyaluronoglucosaminidase has been researched along with Diabetic Angiopathies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, N; Dogné, S; Flamion, B | 1 |
| Dai, A; Dillmann, WH; Donthamsetty, R; Han, Y; Makino, A; Scott, BT; Wang, H; Wang, W; Youssef, KD | 1 |
| Issad, T | 1 |
| Brouwer, CB; Chapman, MJ; de Groot, E; Gort, J; Hoekstra, JB; Holleman, F; Hutten, BA; Kastelein, JJ; Kontush, A; Nieuwdorp, M; Stroes, ES; Vink, H | 1 |
| Fujii, S; Marutsuka, K; Sakamoto, T; Sobel, BE; Woodcock-Mitchell, J | 1 |
1 review(s) available for hyaluronoglucosaminidase and Diabetic Angiopathies
| Article | Year |
|---|---|
Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases.
Topics: Animals; Diabetes Mellitus; Diabetic Angiopathies; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Glycocalyx; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Mechanotransduction, Cellular | 2018 |
4 other study(ies) available for hyaluronoglucosaminidase and Diabetic Angiopathies
| Article | Year |
|---|---|
O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Topics: Animals; Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Cells, Cultured; Connexins; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Gap Junction alpha-5 Protein; Glycosylation; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Male; Mice, Transgenic; N-Acetylglucosaminyltransferases; Neovascularization, Physiologic; Protein Processing, Post-Translational; Signal Transduction; Vasodilation | 2015 |
O-GlcNAcylation of connexin 40: a sweet connection between diabetes and endothelial cell dysfunction? Focus on "O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice".
Topics: Animals; Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelial Cells; Endothelium, Vascular; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Male | 2015 |
Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis.
Topics: Adolescent; Adult; Aged; Atherosclerosis; Carotid Arteries; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Middle Aged; Tunica Intima; Tunica Media | 2007 |
Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes.
Topics: Antibodies; Aorta; Blotting, Western; Cells, Cultured; Culture Media, Conditioned; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fibrinolysis; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1998 |